Fenfen Qin

441 citations
16 papers · 286 indexed · h-index 10
Topics
Pain Mechanisms and Treatments (5 papers)Neuropeptides and Animal Physiology (5 papers)Acupuncture Treatment Research Studies (3 papers)
Partner nations
ChinaHong Kong

In The Last Decade

Fenfen Qin

16 papers receiving 284 citations

Peers

Fenfen Qin
Comparison fields: 5 of 71
  • Molecular Biology 90
  • Physiology 56
  • Complementary and alternative medicine 55
  • Cellular and Molecular Neuroscience 44
  • Public Health, Environmental and Occupational Health 35
Replace Qinmei Sun with:
Qinmei Sun China
Zhigang Lu China
Min-Sun Choi South Korea
Maziar Gooshe Iran
Natalie Clark United Kingdom
Michał Gajewski Poland
Denis Ardid France
Manon Defaye Canada
Deyuan Li China
Ewa Wietrak Poland
Fenfen Qin relative to Qinmei Sun China Qinmei Sun's profile →
Citations per field
00.5×1.5×
Qinmei Sun · 1×
Citations per year

Countries citing papers authored by Fenfen Qin

Since Specialization
Citations

This map shows the geographic impact of Fenfen Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fenfen Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fenfen Qin more than expected).

Fields of papers citing papers by Fenfen Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fenfen Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fenfen Qin. The network helps show where Fenfen Qin may publish in the future.

Co-authorship network of co-authors of Fenfen Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Fenfen Qin. A scholar is included among the top collaborators of Fenfen Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fenfen Qin. Fenfen Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 1
2 7
3 3
4 1
5 2
6 29
7 3
8 21
9 13
10 51
11 9
12 42
13 27
14 11
15 17
16 49

About Fenfen Qin

Fenfen Qin is a scholar working on Complementary and alternative medicine, Cellular and Molecular Neuroscience and Toxicology, having authored 16 papers that have together received 286 indexed citations. Recurring topics across this work include Pain Mechanisms and Treatments (5 papers), Neuropeptides and Animal Physiology (5 papers) and Acupuncture Treatment Research Studies (3 papers). The work is most often cited by research in Complementary and alternative medicine (55 citations), Reproductive Medicine (31 citations) and Biological Psychiatry (7 citations). Fenfen Qin has collaborated with scholars based in China and Hong Kong. Frequent co-authors include Zhigang Lu, Sheng-Feng Lu, Qinmei Sun, Anlong Liu, Qian Wang, Qisheng Wang, Shu-Ping Fu, Jun‐Meng Wang, Dong Zhang and Han Zhang. Their work appears in journals such as Science Translational Medicine, Frontiers in Immunology and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026